生物製剤受託製造のアジア太平洋市場2021年ー2031年:種類別(モノクローナル、抗体、組換え体、タンパク質、ワクチン、分子療法、その他)

調査会社Transparency Market Research社が発行したリサーチレポート(データ管理コード:TMR21DC056)
◆英語タイトル:Biologics Contract Manufacturing Market (Type: Monoclonal, Antibodies, Recombinant, Proteins, Vaccines, Molecular Therapy, and Others) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031
◆発行会社/調査会社:Transparency Market Research
◆商品コード:TMR21DC056
◆発行日:2021年10月12日
◆調査対象地域:アジア太平洋
◆産業分野:医薬品
◆ページ数:139
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後24時間以内)
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD5,795 ⇒換算¥666,425見積依頼/購入/質問フォーム
Site Licence(同一拠点内で共有可)USD8,795 ⇒換算¥1,011,425見積依頼/購入/質問フォーム
Enterprisewide(複数拠点内で共有可)USD11,795 ⇒換算¥1,356,425見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[生物製剤受託製造のアジア太平洋市場2021年ー2031年:種類別(モノクローナル、抗体、組換え体、タンパク質、ワクチン、分子療法、その他)]についてメールでお問い合わせはこちら
Transparency Market Research社の本調査レポートは、生物製剤受託製造のアジア太平洋市場を調査対象とし、序論、仮定・調査手法、エグゼクティブサマリー、市場概要、キーインサイト、種類別分析、国別分析、競争状況などの構成でまとめております。
*** レポート概要(サマリー)***

Asia Pacific Biologics Contract Manufacturing Market – Scope of Report
The latest study collated and published by Transparency Market Research (TMR) analyzes the historical and present scenario of the biologics contract manufacturing market in Asia Pacific to gauge its growth potential. The study presents detailed information about important growth factors, restraints, and key trends that are creating the landscape for growth of the biologics contract manufacturing market in Asia Pacific in order to identify opportunities for stakeholders. The report also provides insightful information about the growth of the biologics contract manufacturing market in Asia Pacific during the forecast period from 2021 to 2031.

The report offers intricate dynamics about different aspects of the biologics contract manufacturing market in Asia Pacific, which aids companies operating in the market in making strategic decisions. TMR’s study also elaborates on the significant changes that are anticipated to boost the growth of the biologics contract manufacturing market in Asia Pacific during the forecast period. It also includes key indicator assessment that highlights growth prospects of the biologics contract manufacturing market in Asia Pacific and provides statistics related to the market in terms of value (US$ Mn).

This study covers detailed segmentation of the biologics contract manufacturing market in Asia Pacific, along with key information and competition outlook. The report provides company profiles of players that dominate the biologics contract manufacturing market in Asia Pacific, wherein various developments, expansions, and winning strategies adopted by these players have been presented in detail.

Key Questions Answered in TMR’s Report on Asia Pacific Biologics Contract Manufacturing Market

The report provides detailed information about the biologics contract manufacturing market in Asia Pacific based on comprehensive research on various factors that play a key role in accelerating the growth of the market. Information mentioned in the report answers path-breaking questions for companies that currently operate in the biologics contract manufacturing market in Asia Pacific and are looking for innovative methods to create a unique benchmark in the market in order to help them design successful strategies and make target-driven decisions.

Which segment of the biologics contract manufacturing market in Asia Pacific would emerge as a major revenue generator during the forecast period?
How are key market players successfully earning revenue in the biologics contract manufacturing market in Asia Pacific?
What would be the Y-o-Y growth trend of the biologics contract manufacturing market in Asia Pacific between 2021 and 2031?
What are the winning imperatives of leading players operating in the biologics contract manufacturing market in Asia Pacific?

Research Methodology – Asia Pacific Biologics Contract Manufacturing Market

The research methodology adopted by analysts for compiling the report on the biologics contract manufacturing market in Asia Pacific is based on detailed primary as well as secondary research. With the help of in-depth insights of the market-affiliated information obtained and endorsed by market-admissible sources, analysts have offered riveting observations and authentic forecasts of the biologics contract manufacturing market in Asia Pacific.

Primary research involved interviews with market stakeholders, investors, brand managers, vice presidents, and sales & marketing managers. Based on data obtained through interviews of genuine sources, analysts have emphasized the changing scenario of the biologics contract manufacturing market in Asia Pacific.

Secondary research involved study of annual report publications, white papers, market association publications, and company websites to obtain the necessary understanding of the biologics contract manufacturing market in Asia Pacific.

*** レポート目次(コンテンツ)***

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global & Asia Pacific Biologics Contract Manufacturing Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global & Asia Pacific Biologics Contract Manufacturing Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Biologics Contract Manufacturing: Overview
5.2. Trends in Biopharma Contract Manufacturing
5.3. Key Industry Events (mergers, acquisitions, collaborations, approvals, etc.)
5.4. COVID-19 Pandemic Impact on Industry
6. Global & Asia Pacific Biologics Contract Manufacturing Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Type, 2017–2031
6.3.1. Monoclonal Antibodies
6.3.2. Recombinant Proteins
6.3.3. Vaccines
6.3.4. Molecular Therapy
6.3.5. Others
6.4. Market Attractiveness Analysis, by Type
7. Asia Pacific Biologics Contract Manufacturing Market Analysis and Forecast, by Country/Sub-Region
7.1. Key Findings
7.2. Market Value Forecast, by Country/Sub-Region
7.2.1. Japan
7.2.2. South Korea
7.2.3. Taiwan
7.2.4. Singapore
7.2.5. Thailand
7.2.6. India
7.2.7. Rest of Asia Pacific
7.3. Market Attractiveness Analysis, by Country/Sub-Region
8. Japan Biologics Contract Manufacturing Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. Market Value Forecast, by Type, 2017–2031
8.2.1. Monoclonal Antibodies
8.2.2. Recombinant Proteins
8.2.3. Vaccines
8.2.4. Molecular Therapy
8.2.5. Others
8.3. Market Attractiveness Analysis
8.3.1. By Type
9. South Korea Biologics Contract Manufacturing Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Type, 2017–2031
9.2.1. Monoclonal Antibodies
9.2.2. Recombinant Proteins
9.2.3. Vaccines
9.2.4. Molecular Therapy
9.2.5. Others
9.3. Market Attractiveness Analysis
9.3.1. By Type
10. Taiwan Biologics Contract Manufacturing Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2017–2031
10.2.1. Monoclonal Antibodies
10.2.2. Recombinant Proteins
10.2.3. Vaccines
10.2.4. Molecular Therapy
10.2.5. Others
10.3. Market Attractiveness Analysis
10.3.1. By Type
11. Singapore Biologics Contract Manufacturing Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2017–2031
11.2.1. Monoclonal Antibodies
11.2.2. Recombinant Proteins
11.2.3. Vaccines
11.2.4. Molecular Therapy
11.2.5. Others
11.3. Market Attractiveness Analysis
11.3.1. By Type
12. Thailand Biologics Contract Manufacturing Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2017–2031
12.2.1. Monoclonal Antibodies
12.2.2. Recombinant Proteins
12.2.3. Vaccines
12.2.4. Molecular Therapy
12.2.5. Others
12.3. Market Attractiveness Analysis
12.3.1. By Type
13. India Biologics Contract Manufacturing Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2017–2031
13.2.1. Monoclonal Antibodies
13.2.2. Recombinant Proteins
13.2.3. Vaccines
13.2.4. Molecular Therapy
13.2.5. Others
13.3. Market Attractiveness Analysis
13.3.1. By Type
14. Rest of Asia Pacific Biologics Contract Manufacturing Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2017–2031
14.2.1. Monoclonal Antibodies
14.2.2. Recombinant Proteins
14.2.3. Vaccines
14.2.4. Molecular Therapy
14.2.5. Others
14.3. Market Attractiveness Analysis
14.3.1. By Type
15. Competition Landscape
15.1. Market Player – Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Lonza Group
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Strategic Overview
15.3.1.4. SWOT Analysis
15.3.2. Samsung Biologics Co., Ltd.
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Strategic Overview
15.3.2.4. SWOT Analysis
15.3.3. Patheon by Thermo Fisher Scientific, Inc.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Strategic Overview
15.3.3.4. SWOT Analysis
15.3.4. Siegfried Holding AG
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Strategic Overview
15.3.4.4. SWOT Analysis
15.3.5. Cambrex Corporation
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Strategic Overview
15.3.5.4. SWOT Analysis
15.3.6. Boehringer Ingelheim
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Strategic Overview
15.3.6.4. SWOT Analysis
15.3.7. Recipharm Pharmaceuticals
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Strategic Overview
15.3.7.4. SWOT Analysis
15.3.8. Catalent Inc.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Strategic Overview
15.3.8.4. SWOT Analysis
15.3.9. WuXi Biologics
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Strategic Overview
15.3.9.4. SWOT Analysis
15.3.10. Fujifilm Holding Corporation
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. Strategic Overview
15.3.10.4. SWOT Analysis
15.3.11. AbbVie, Inc.
15.3.11.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.11.2. Product Portfolio
15.3.11.3. Strategic Overview
15.3.11.4. SWOT Analysis

List of Tables

Table 01: Global Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017‒2031

Table 02: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Country/Sub-Region, 2017–2031

Table 03: Japan Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 04: South Korea Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 05: Taiwan Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 06: Singapore Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 07: Thailand Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 08: India Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017–2031

Table 09: Rest of Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, by Type, 2017–2031

List of Figures

Figure 01: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Asia Pacific Biologics Contract Manufacturing Market Value Share, by Type, 2020

Figure 03: Asia Pacific Biologics Contract Manufacturing Market Value Share, by Country/Sub-Regions, 2020

Figure 04: Asia Pacific Biologics Contract Manufacturing Market Value Share Analysis, by Type, 2020 and 2031

Figure 05: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

Figure 06: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), by Monoclonal Antibodies, 2017‒2031

Figure 07: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), by Recombinant Proteins, 2017‒2031

Figure 08: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), by Vaccines, 2017‒2031

Figure 09: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), by Molecular Therapy, 2017‒2031

Figure 10: Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn), by Others, 2017–2031

Figure 11: Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, by Region, 2021–2031

Figure 12: Asia Pacific Biologics Contract Manufacturing Market Value Share Analysis, by Region, 2020 and 2031

Figure 13: Japan Biologics Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 14: Japan Biologics Contract Manufacturing Market Value Share (%), by Type, 2020 and 2031

Figure 15: Japan Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

Figure 16: South Korea Biologics Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 17: South Korea Biologics Contract Manufacturing Market Value Share (%), by Type, 2020 and 2031

Figure 18: South Korea Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

Figure 19: Taiwan Biologics Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 20: Taiwan Biologics Contract Manufacturing Market Value Share (%), by Type, 2020 and 2031

Figure 21: Taiwan Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

Figure 22: Singapore Biologics Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 23: Singapore Biologics Contract Manufacturing Market Value Share (%), by Type, 2020 and 2031

Figure 24: Singapore Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

Figure 25: Thailand Biologics Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 26: Thailand Biologics Contract Manufacturing Market Value Share (%), by Type, 2020 and 2031

Figure 27: Thailand Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

Figure 28: India Biologics Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 29: India Biologics Contract Manufacturing Market Value Share (%), by Type, 2020 and 2031

Figure 30: India Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

Figure 31: Rest of Asia Pacific Biologics Contract Manufacturing Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2031

Figure 32: Rest of Asia Pacific Biologics Contract Manufacturing Market Value Share (%), by Type, 2020 and 2031

Figure 33: Rest of Asia Pacific Biologics Contract Manufacturing Market Attractiveness Analysis, by Type, 2021–2031

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • 自動ドアの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2021)
    Automatic door is powered open and closed either by electricity, spring, or both while a person or a vehicle passing through it. Automatic door is always used in high-end hotels, large super markets, high-end office buildings, garages, banks, and other infrastructures (such as airports, stations, et …
  • キャンプ用品用折りたたみ式輸送カートの世界市場 2021年:メーカー別、地域別、種類・用途別
    The Folding Transport Cart for Camping Equipment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi …
  • 航空宇宙及び防衛の日本市場
    Aerospace & Defense in Japan Summary Aerospace & Defense in Japan industry profile provides top-line qualitative and quantitative summary information including: market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial me …
  • ピュアカシミアの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Pure Cashmere Revenue, means the sales value of Pure Cashmere This report studies sales (consumption) of Pure Cashmere in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, …
  • 日本のシャンプー市場:市場規模、成長、予測
    SummaryShampoo - products containing soap or detergents necessary to wash the hair, can also include additional agents like conditioners, dandruff fighting agents, medicated / therapeutic agents etc. Product category includes all 2-in-1 shampoos and conditioners, regular shampoos, anti-dandruff sham …
  • 世界の3D-TSVウェハー市場2017
    3D-TSV Wafers Market Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, G …
  • 複合接着剤の世界市場:成長・動向・予測(2020年-2025年)
    The market for composite adhesives is expected to grow at a CAGR of over 5% during the forecast period. The major factor driving the growth of the market studied is the increasing demand for adhesives over conventional binding techniques in various end-user industries. On the flip side, the slowdown …
  • 産業用ビデオカメラの世界市場:販売動向2017
    Notes:Sales, means the sales volume of Industrial Video Cameras Revenue, means the sales value of Industrial Video Cameras This report studies sales (consumption) of Industrial Video Cameras in Global market, especially in United States, China, Europe and Japan, focuses on top players in these regio …
  • 土壌改良資材の世界市場2018-2027
    According to Stratistics MRC, the Global Soil Amendments Market is accounted for $2.91 billion in 2018 and is expected to reach $8.54 billion by 2027 growing at a CAGR of 12.7% during the forecast period. Increasing requirement from organic food products and rising consciousness related to soil heal …
  • チリの心臓血管手術装置市場見通し
    Chile Cardiovascular Surgery Devices Market Outlook to 2022 Summary GlobalData’s new report, Chile Cardiovascular Surgery Devices Market Outlook to 2022, provides key market data on the Chile Cardiovascular Surgery Devices market. The report provides value, in millions of US dollars, volume (in unit …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(TMR21DC056 )"生物製剤受託製造のアジア太平洋市場2021年ー2031年:種類別(モノクローナル、抗体、組換え体、タンパク質、ワクチン、分子療法、その他)" (英文:Biologics Contract Manufacturing Market (Type: Monoclonal, Antibodies, Recombinant, Proteins, Vaccines, Molecular Therapy, and Others) - Asia Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031)はTransparency Market Research社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。